WO2020186979A1 - 一种防护器具、杀菌消毒复合片材及其制造方法 - Google Patents

一种防护器具、杀菌消毒复合片材及其制造方法 Download PDF

Info

Publication number
WO2020186979A1
WO2020186979A1 PCT/CN2020/076616 CN2020076616W WO2020186979A1 WO 2020186979 A1 WO2020186979 A1 WO 2020186979A1 CN 2020076616 W CN2020076616 W CN 2020076616W WO 2020186979 A1 WO2020186979 A1 WO 2020186979A1
Authority
WO
WIPO (PCT)
Prior art keywords
sterilization
disinfection
nonwoven fabric
mass
catalyst
Prior art date
Application number
PCT/CN2020/076616
Other languages
English (en)
French (fr)
Inventor
李国培
李海镛
Original Assignee
深圳市康风环境科技发展有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN201920361187.6U external-priority patent/CN210125297U/zh
Priority claimed from CN201910212050.9A external-priority patent/CN109794164A/zh
Application filed by 深圳市康风环境科技发展有限公司 filed Critical 深圳市康风环境科技发展有限公司
Priority to KR1020207012626A priority Critical patent/KR20200113184A/ko
Priority to JP2020526223A priority patent/JP2021518769A/ja
Publication of WO2020186979A1 publication Critical patent/WO2020186979A1/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/08—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A—HUMAN NECESSITIES
    • A41—WEARING APPAREL
    • A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D13/00—Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches
    • A41D13/05—Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches protecting only a particular body part
    • A41D13/11—Protective face masks, e.g. for surgical use, or for use in foul atmospheres
    • A41D13/1192—Protective face masks, e.g. for surgical use, or for use in foul atmospheres with antimicrobial agent
    • A—HUMAN NECESSITIES
    • A41—WEARING APPAREL
    • A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D31/00—Materials specially adapted for outerwear
    • A41D31/04—Materials specially adapted for outerwear characterised by special function or use
    • A41D31/30—Antimicrobial, e.g. antibacterial
    • A41D31/305—Antimicrobial, e.g. antibacterial using layered materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00987—Apparatus or processes for manufacturing non-adhesive dressings or bandages
    • A61F13/00991—Apparatus or processes for manufacturing non-adhesive dressings or bandages for treating webs, e.g. for moisturising, coating, impregnating or applying powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive plasters or dressings
    • A61F13/0203—Adhesive plasters or dressings having a fluid handling member
    • A61F13/0206—Adhesive plasters or dressings having a fluid handling member the fluid handling member being absorbent fibrous layer, e.g. woven or nonwoven absorbent pad, island dressings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive plasters or dressings
    • A61F13/0246—Adhesive plasters or dressings characterised by the skin adhering layer
    • A61F13/0253—Adhesive plasters or dressings characterised by the skin adhering layer characterized by the adhesive material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive plasters or dressings
    • A61F13/0276—Apparatus or processes for manufacturing adhesive dressings or bandages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D53/00—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols
    • B01D53/34—Chemical or biological purification of waste gases
    • B01D53/46—Removing components of defined structure
    • B01D53/72—Organic compounds not provided for in groups B01D53/48 - B01D53/70, e.g. hydrocarbons
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D53/00—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols
    • B01D53/34—Chemical or biological purification of waste gases
    • B01D53/74—General processes for purification of waste gases; Apparatus or devices specially adapted therefor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D53/00—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols
    • B01D53/34—Chemical or biological purification of waste gases
    • B01D53/74—General processes for purification of waste gases; Apparatus or devices specially adapted therefor
    • B01D53/86—Catalytic processes
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J11/00—Features of adhesives not provided for in group C09J9/00, e.g. additives
    • C09J11/02—Non-macromolecular additives
    • C09J11/04—Non-macromolecular additives inorganic
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J11/00—Features of adhesives not provided for in group C09J9/00, e.g. additives
    • C09J11/02—Non-macromolecular additives
    • C09J11/06—Non-macromolecular additives organic
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J11/00—Features of adhesives not provided for in group C09J9/00, e.g. additives
    • C09J11/08—Macromolecular additives
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J163/00—Adhesives based on epoxy resins; Adhesives based on derivatives of epoxy resins
    • D—TEXTILES; PAPER
    • D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
    • D04H1/04—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres having existing or potential cohesive properties, e.g. natural fibres, prestretched or fibrillated artificial fibres
    • D04H1/08—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres having existing or potential cohesive properties, e.g. natural fibres, prestretched or fibrillated artificial fibres and hardened by felting; Felts or felted products
    • D04H1/16—Laminated felts in which the separate layers are united by a felting process
    • D—TEXTILES; PAPER
    • D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M11/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising
    • D06M11/07—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with halogens; with halogen acids or salts thereof; with oxides or oxyacids of halogens or salts thereof
    • D06M11/11—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with halogens; with halogen acids or salts thereof; with oxides or oxyacids of halogens or salts thereof with halogen acids or salts thereof
    • D06M11/17—Halides of elements of Groups 3 or 13 of the Periodic System
    • D—TEXTILES; PAPER
    • D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M11/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising
    • D06M11/07—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with halogens; with halogen acids or salts thereof; with oxides or oxyacids of halogens or salts thereof
    • D06M11/30—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with halogens; with halogen acids or salts thereof; with oxides or oxyacids of halogens or salts thereof with oxides of halogens, oxyacids of halogens or their salts, e.g. with perchlorates
    • D—TEXTILES; PAPER
    • D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M11/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising
    • D06M11/77—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with silicon or compounds thereof
    • D06M11/79—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with silicon or compounds thereof with silicon dioxide, silicic acids or their salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00089—Wound bandages
    • A61F2013/00238—Wound bandages characterised by way of knitting or weaving
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00902—Plasters containing means
    • A61F2013/0091—Plasters containing means with disinfecting or anaesthetics means, e.g. anti-mycrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • D—TEXTILES; PAPER
    • D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2509/00—Medical; Hygiene
    • D10B2509/02—Bandages, dressings or absorbent pads
    • D10B2509/022—Wound dressings

Definitions

  • This application relates to the technical field of sterilization and disinfection, in particular to a protective device, a sterilization and sterilization composite sheet, and a method for manufacturing the sterilization and sterilization composite sheet.
  • polyester materials with high air permeability and low resistance are required to be used in composite materials of filter bags, filter elements and purifiers.
  • the base material manufactured by the polyester long fiber process is mostly appearing on the market.
  • the substrate of this long fiber process is limited by the influence of the long fiber process, and is affected by factors such as uneven cloth surface, low air permeability, and high cost, resulting in a series of problems such as unsatisfactory performance effects of air filter products.
  • the sterilization and disinfection materials used in general band-aids are low in effect and cannot be sterilized for viral skin. Therefore, the application range is narrow and cannot meet the needs of users.
  • the inventor of the present application has conducted in-depth research to find a new sterilization product to meet the daily needs of users.
  • the purpose of the present application is to provide a protective device, a sterilization and disinfection composite sheet and a manufacturing method thereof, so as to further meet the user's daily sterilization and disinfection needs and improve user experience.
  • this application provides a sterilization and disinfection composite sheet.
  • the sterilization and sterilization composite sheet is provided with at least a first sheet layer, and the first sheet layer includes meltblown Method nonwoven fabric and a sterilization and disinfection catalyst compounded on the meltblown nonwoven fabric in powder form, the sterilization and disinfection catalyst is used to generate gas-phase free radicals including ⁇ OH, ⁇ ClO 2 , ⁇ HO 2 , ⁇ O
  • gas-phase free radicals including ⁇ OH, ⁇ ClO 2 , ⁇ HO 2 , ⁇ O
  • the sterilization and disinfection composite sheet is further provided with at least a second sheet layer, and the second sheet layer includes a spunbonded nonwoven fabric, the meltblown nonwoven fabric and the The spunbonded nonwoven fabric is compounded and consolidated and laminated, and the sterilization catalyst is compounded between the meltblown nonwoven fabric and the spunbonded nonwoven fabric.
  • the melt-blown nonwoven fabric is made by PP melt-blown, PP melt-blown combined with PET, or electrostatic cotton combined with PET, and its unit weight per square meter is between 80-120g/m 2 , the thickness is between 0.45-0.7mm, and the efficiency is between 95%-99.99%.
  • the sterilization and disinfection catalyst includes an inorganic porous carrier, wherein the sterilization and disinfection catalyst is impregnated with a stable chlorine dioxide solution or a stable chlorite solution through the inorganic porous carrier, and then passes through It is prepared by drying below a preset temperature threshold to a moisture content less than a rated threshold.
  • the various active particles can be used to adsorb and oxidize to kill microorganisms or formaldehyde.
  • the sterilization and disinfection catalyst is a powdery particulate matter with a pore density of 30 to 60 mesh, and a unit weight per square meter of 50 to 200 g/m 2 .
  • the inorganic porous carrier is cordierite honeycomb ceramic or mullite honeycomb ceramic
  • the inorganic porous carrier is at least one or more combinations of aluminum oxide, silicon dioxide, zeolite, sepiolite, montmorillonite and diatomaceous earth.
  • the stable chlorine dioxide solution is prepared by using chlorine dioxide gas and sodium carbonate peroxyhydrate, and the chlorine dioxide content is 2%-5%;
  • the stable chlorite solution includes chlorite with a component content of 0.1-10, a stabilizer with a component content of 0.1-5, a buffer with a component content of 0.05-15, and a component content of 0.1 -75, wherein the chlorite is an alkali metal salt of chlorite or an alkaline earth metal salt of chlorite.
  • the sterilization and disinfection composite sheet further includes a sticky part for sticking, and the sticky part extends from the sterilization and disinfection composite sheet to protruding from the outer periphery, so that the sterilization and disinfection composite sheet The material sticks to cover the wound or infected skin, or sticks to the mask.
  • the adhesive part includes an elastic substrate and an adhesive formed on the elastic substrate, and the adhesive includes 30 parts by mass of epoxy resin and 21 parts by mass.
  • the plasticized substitute materials used to achieve bonding in the first sheet layer and/or the second sheet layer are: trioctyl trimellitate, epoxy soybean oil, DINCH, polymer plasticizer, ethylene-vinyl acetate copolymer or polyurethane, and does not include phthalic anhydride dibutyl ester.
  • the present application also provides a protective device.
  • the protective device adopts the sterilization and disinfection composite sheet as described above, and the sterilization and sterilization composite sheet includes a first sheet. Layer and two second sheet layers, the first sheet layer is sandwiched between the two second sheet layers, the first sheet layer includes meltblown non-woven fabric and composite in powder form
  • the sterilization and disinfection catalyst is used to generate a variety of active particles including gas-phase free radicals ⁇ OH, ⁇ ClO 2 , ⁇ HO 2 , ⁇ O, and the second
  • the sheet layer includes a spunbonded nonwoven fabric, the meltblown nonwoven fabric and the spunbonded nonwoven fabric are compounded and consolidated, and the sterilization catalyst is compounded with the meltblown nonwoven fabric. Between the woven fabric and the spunbonded non-woven fabric.
  • the protective device is a mask, wound care patch or skin infection care patch.
  • the present application also provides a method for manufacturing a sterilization and disinfection composite sheet.
  • the manufacturing method includes:
  • a sterilization and disinfection catalyst in powder form is prepared, and the sterilization and disinfection catalyst is used to generate a variety of active particles including gas-phase free radicals ⁇ OH, ⁇ ClO 2 , ⁇ HO 2 , and ⁇ O;
  • the meltblown nonwoven fabric and the spunbonded nonwoven fabric are prepared, and the meltblown nonwoven fabric, the spunbonded nonwoven fabric and the sterilization catalyst are composited and consolidated and laminated, wherein ,
  • the sterilization catalyst is compounded on the meltblown nonwoven fabric to form a first sheet layer, the spunbonded nonwoven fabric forms a second sheet layer, and the sterilization catalyst is compounded on the meltblown fabric Between the French nonwoven fabric and the spunbonded nonwoven fabric.
  • the steps of preparing the sterilization catalyst in powder form specifically include:
  • An inorganic porous carrier is prepared, the inorganic porous carrier is immersed in a stable chlorine dioxide solution or a stable chlorite solution, and dried below a preset temperature threshold to a moisture content less than a rated threshold to prepare the sterilization catalyst;
  • meltblown nonwoven fabric and the spunbonded nonwoven fabric are prepared, and the meltblown nonwoven fabric, the spunbonded nonwoven fabric and the sterilization catalyst are composited and consolidated and laminated After the steps, it also includes:
  • An elastic substrate is disposed on the first sheet layer and/or the second sheet layer, and an adhesive is formed on the elastic substrate to form an adhesive part for sticking, wherein the
  • the adhesive includes 30 parts by mass of epoxy resin, 21 parts by mass of alicyclic amine, 7 parts by mass of dodecylglycerol ether, and 3 parts by mass of carboxymethyl fiber Sodium, 0.6 parts by mass of nano zinc oxide, 1.2 parts by mass of silica gel, 0.3 parts by mass of talc, 0.2 parts by mass of chitin, and 5 parts by mass Ethylene glycol.
  • the present application provides a protective device, a sterilization and disinfection composite sheet and a manufacturing method thereof.
  • the sterilization and sterilization composite sheet is provided with at least a first sheet layer, and the first sheet layer includes a meltblown nonwoven
  • the cloth and the sterilization and disinfection catalyst compounded on the meltblown non-woven fabric in powder form are used to generate a variety of active particles including gas-phase free radicals ⁇ OH, ⁇ ClO 2 , ⁇ HO 2 , ⁇ O in order to In the case of wounds, nose and mouth or infected skin, the various active particles are used for adsorption, oxidation and/or purification.
  • the present application can combine the functions of a sterilization and disinfection catalyst with band-aids or masks.
  • it can also sterilize the human body or microorganisms in the air, providing users with a safer and cleaner experience and guarantee User health and safety, improve user experience, and meet more daily needs of users.
  • this application takes advantage of the extremely limited spatial distance of the effective effect of the gas-phase free radicals, and the life time of the gas-phase free radicals is only about 10 nanoseconds, so they will not enter the human body and avoid harm to the human body. .
  • FIG. 1 is a schematic structural diagram of an embodiment of a sterilization and disinfection composite sheet according to this application.
  • Figure 2 is a schematic cross-sectional view of the sterilization and disinfection composite sheet of Figure 1 along the direction A-A'.
  • Fig. 3 is a schematic flow diagram of an embodiment of a method for manufacturing a sterilization and disinfection composite sheet according to the present application.
  • the sterilization and disinfection composite sheet of the present application is provided with at least a first sheet layer 11, and the first sheet layer 11 includes a meltblown nonwoven fabric 110 and The sterilization and disinfection catalyst 111 compounded on the meltblown non-woven fabric 110 in powder form, and the sterilization and disinfection catalyst 111 is used to generate gas-phase free radicals ⁇ OH, ⁇ ClO 2 , ⁇ HO 2 , ⁇ O
  • the active particles can be adsorbed, oxidized and/or purified by the various active particles in wounds, nose and mouth or infected skin.
  • the high-efficiency sterilization and disinfection effect of the band-aid can be realized, and the mask can also be installed on the mask for sterilization, disinfection and purification, or sterilization and disinfection of various skin diseases, etc., to meet the different needs of users.
  • the active particles of the gas-phase radicals ⁇ OH, ⁇ ClO 2 , ⁇ HO 2 , and ⁇ O described in this embodiment have an effective movement distance in the gas phase in micrometers as the unit of measurement, and The lifetime of the gas-phase free radicals is only about 10 nanoseconds, that is, they can basically not be separated from the carrier of the sterilization catalyst 111.
  • the gas-phase free radicals of this embodiment ⁇ OH, ⁇ ClO 2 , ⁇ HO 2 , ⁇
  • the various active particles of O will not enter the human body as a strong oxidant to avoid unnecessary harm to the human body, but are only effective within a very small distance of the carrier of the sterilization catalyst 111, and are effective against attempts to cross the sterilization
  • the bacteria and viruses of the disinfection catalyst 111 are effectively disinfected to ensure the safety of users.
  • the sterilization and disinfection composite sheet of this embodiment is further provided with at least a second sheet layer 12, and the second sheet layer 12 includes a spunbonded nonwoven fabric, and the meltblown nonwoven fabric 110 and the spunbonded nonwoven fabric are composited and consolidated and laminated, and the sterilization catalyst 111 is composited between the meltblown nonwoven fabric 110 and the spunbonded nonwoven fabric.
  • the sterilization and disinfection composite sheet of this embodiment is set in the composite mode of SM, that is, a meltblown nonwoven fabric 110 (M) is combined with a spunbonded nonwoven fabric (S), and in other implementations
  • M meltblown nonwoven fabric 110
  • S spunbonded nonwoven fabric
  • it can also be composited into SMS, SMMMS, etc., and different materials can be composited on different M layers as needed, and different functions can be realized, which is not limited here.
  • it can adopt a one-step method for compounding, or a two-step method for compounding, and it will not be described in detail within the scope of those skilled in the art.
  • This application adopts the method of meltblown nonwoven fabric 110 (M) combined with spunbonded nonwoven fabric (S), and makes full use of the characteristics of the two nonwoven fabrics, that is, to ensure the overall flexibility, structural strength, and The elastic requirements for air permeability and filtration rate are improved.
  • the composite consolidation and lamination method adopted in this embodiment can be hot rolling, needle punching, spunlacing and ultrasonic waves.
  • the meltblown nonwoven fabric 110 is made by PP (polypropylene) meltblown, PP meltblown combined with PET (polyester), or electrostatic cotton combined with PET, and its square meter mass
  • the weight is between 80-120g/m 2 (grams per square meter), the thickness is between 0.45-0.7mm (millimeters), and the efficiency is between 95%-99.99%.
  • the square meter mass unit weight can be 90g/m 2 , 95g/m 2 , 100g/m 2 , 105g/m 2 or 110g/m 2 , and the thickness can be 0.5mm, 0.55mm, 0.6mm and 0.7 mm, the efficiency is 95%, 96%, 99% and 99.99%, which can be set according to the application route.
  • the sterilization and disinfection catalyst 111 of this embodiment includes an inorganic porous carrier, wherein the sterilization and disinfection catalyst 111 is impregnated with a stable chlorine dioxide solution or a stable chlorite via the inorganic porous support.
  • the solution is prepared by drying below a preset temperature threshold to a moisture content less than a rated threshold.
  • the various active particles can be used to adsorb and oxidize to kill microorganisms or formaldehyde.
  • the preset temperature threshold may be 85°C or 90°C, etc.
  • the rated threshold may be 10%, 9%, 8%, or 7%, etc.
  • the sterilization and disinfection catalyst 111 in this embodiment is a powdery particulate matter with a pore density of 30 to 60 mesh, and its square meter mass unit weight is between 50-200 g/m 2 .
  • 40 mesh, 45 mesh or 50 mesh can be used, and the unit weight per square meter can be 60g/m 2 , 70g/m 2 , 80g/m 2 , 90g/m 2 , 100g/m 2 , 160g/m 2. 140g/m 2 etc., which can be specifically set according to the application route.
  • the inorganic porous carrier is cordierite honeycomb ceramic or mullite honeycomb ceramic; or, the inorganic porous carrier is alumina, silica, zeolite, sepiolite, montmorillonite At least one or more combinations of stone and diatomaceous earth.
  • the specific method can be mixed, which is not limited here.
  • the stable chlorine dioxide solution in this embodiment is prepared by using chlorine dioxide gas and sodium carbonate peroxyhydrate, and the chlorine dioxide content is 2%-5%.
  • the chlorine dioxide content can be 3%, 4%.
  • the stable chlorite solution of this embodiment includes chlorite with a component content of 0.1-10, a stabilizer with a component content of 0.1-5, a buffer with a component content of 0.05-15, and An absorbent with a component content of 0.1-75, wherein the chlorite is an alkali metal salt of chlorous acid or an alkaline earth metal salt of chlorous acid.
  • the sheet also includes an adhesive part 13 for sticking, which extends from the sterilization and disinfection composite sheet to protruding from the periphery, so as to stick the sterilization and sterilization composite sheet to cover the wound or infection. On the skin, or stick to the mask.
  • the shape of the adhesive part 13 can be arranged in different ways for different parts such as joints, fingers, head, etc., such as a ring shape, a plurality of adhesive parts 13 arranged at intervals, and the like.
  • the adhesive portion 13 of the present embodiment includes an elastic substrate and an adhesive formed on the elastic substrate, and the adhesive includes 30 parts by mass of epoxy resin, and the number of parts by mass is 21 parts of alicyclic amine, 7 parts by mass of dodecylglycerol ether, 3 parts by mass of sodium carboxymethyl cellulose, 0.6 parts by mass of nano zinc oxide, parts by mass It is 1.2 parts by mass of silica gel, 0.3 parts by mass of talc, 0.2 parts by mass of chitin, and 5 parts by mass of ethylene glycol.
  • Adopting the adhesive of this embodiment can greatly improve the skin experience, provide better air permeability, ensure the adhesive strength, and have a good waterproof effect.
  • the plasticized substitute materials used for bonding in the first sheet layer 11 and/or the second sheet layer 12 of this embodiment are: trioctyl trimellitate, epoxy resin Soybean oil, DINCH (non-phthalate), polymer plasticizer, ethylene-vinyl acetate copolymer or polyurethane, and does not include phthalic anhydride dibutyl ester. It is not difficult to understand that this embodiment no longer uses phthalic anhydride dibutyl ester as a plasticizer to avoid harm to the human body when used as a protective device, thereby ensuring human health and improving the safety performance of the product.
  • the protective device adopts the sterilization and disinfection composite sheet as described above, and the sterilization and disinfection
  • the composite sheet includes a first sheet layer (M) and two second sheet layers (S), the first sheet layer (M) is sandwiched between the two second sheet layers (S) ,
  • the first sheet layer (M) includes a meltblown nonwoven fabric and a sterilization catalyst compounded on the meltblown nonwoven fabric in powder form, and the sterilization catalyst is used to generate a gas free
  • the second sheet layer (S) includes a spunbonded nonwoven fabric, and the meltblown nonwoven fabric is compatible with the spunbonded nonwoven fabric.
  • the second sheet layer (S) includes various active particles based on ⁇ OH, ⁇ ClO 2 , ⁇ HO 2 and ⁇ O.
  • the bonded nonwoven fabric is compounded and consolidated and laminated, and the sterilization and disinfection catalyst is compounded between the meltblown nonwoven fabric and the spunbonded nonwoven fabric.
  • the sterilization and disinfection composite sheet used in the protective device of this embodiment is set by SMS non-woven fabrics (Spun bond, Melt blown, Spun bond Nonwovens), that is, composite non-woven fabrics, which can have strong It has the advantages of high performance, good filtering performance, no adhesive, non-toxicity, etc., and the performance of the sterilization and disinfection composite sheet is compounded, and it can be well used for protection and care in life.
  • SMS non-woven fabrics spun bond, Melt blown, Spun bond Nonwovens
  • the protective device in this embodiment may be a mask, a wound care patch, or a skin infection care patch.
  • the protective device of this embodiment passes through various active particles of gas-phase free radicals ⁇ OH, ⁇ ClO 2 , ⁇ HO 2 , and ⁇ O.
  • the bacteria and viruses inhaled in the mask from the outside can be eliminated to kill Avoid external infection.
  • it can kill bacteria and viruses exhaled from the mask wearer who is the infected user, and prevent it from spreading to the external environment and causing infection to others.
  • the mask of the present application can also release trace amounts of ClO 2 can reach the mouth and respiratory tract of the mask wearer, which can not only realize sterilization and disinfection, but also promote the body's metabolism through its antioxidant effect.
  • this application can effectively prevent and kill coronaviruses through various active particles of gas-phase free radicals ⁇ OH, ⁇ ClO 2 , ⁇ HO 2 and ⁇ O, such as SARS and COVID-19. Coronavirus, etc., can help infected people recover quickly.
  • This application also provides a manufacturing method for manufacturing the sterilization and disinfection composite sheet described in the above embodiment. Specifically, the manufacturing method described in this embodiment includes but is not limited to the following step.
  • step S301 a powdered sterilization and disinfection catalyst 111 is prepared, and the sterilization and disinfection catalyst 111 is used to generate a variety of active particles including gas-phase free radicals ⁇ OH, ⁇ ClO 2 , ⁇ HO 2 , and ⁇ O;
  • Step S302 the meltblown nonwoven fabric 110 and the spunbonded nonwoven fabric are prepared, and the meltblown nonwoven fabric 110, the spunbonded nonwoven fabric and the sterilization catalyst 111 are combined and combined Consolidation lamination, wherein the sterilization catalyst 111 is compounded on the meltblown nonwoven fabric 110 to form the first sheet layer 11, and the spunbonded nonwoven fabric forms the second sheet layer 12 and The sterilization catalyst 111 is compounded between the meltblown nonwoven fabric 110 and the spunbonded nonwoven fabric.
  • the step of preparing the sterilization catalyst 111 in powder form in this embodiment specifically includes: preparing an inorganic porous carrier, and impregnating the inorganic porous carrier with a stable chlorine dioxide solution or a stable chlorine dioxide solution.
  • the acid salt solution is dried below the preset temperature threshold to the moisture content of less than the rated threshold to prepare the sterilization catalyst 111.
  • the meltblown nonwoven fabric 110 and the spunbonded nonwoven fabric are prepared in this embodiment, and the meltblown nonwoven fabric 110, the spunbonded nonwoven fabric and the After the step of compounding, consolidating and laminating the sterilization catalyst 111, it further includes: arranging an elastic substrate on the first sheet layer 11 and/or the second sheet layer 12, and placing the An adhesive is formed on the elastic substrate to form the adhesive part 13 for sticking, wherein the adhesive includes 30 parts by mass of epoxy resin, 21 parts by mass of alicyclic amine, and mass parts of 7 parts of dodecylglycerol ether, 3 parts by mass of sodium carboxymethyl cellulose, 0.6 parts by mass of nano zinc oxide, 1.2 parts by mass of silica gel, 0.3 parts by mass Parts of talc, 0.2 parts by mass of chitin, and 5 parts by mass of ethylene glycol.
  • the adhesive includes 30 parts by mass of epoxy resin, 21 parts by mass of alicyclic amine, and mass parts of 7 parts of dodecylglycerol ether
  • the silica gel in this embodiment may be fine-pored silica gel with an average pore distance of 2.0-3.0 nm (nanometers).
  • an elastic substrate is disposed on the first sheet layer 11 and/or the second sheet layer 12, and an adhesive is formed on the elastic substrate to form an adhesive for bonding.
  • the step of sticking part 13 may include the following specific steps to prepare an adhesive:
  • Step (1) According to the mass ratio, mix the epoxy resin and silica gel, stir for 30-60min (minutes), heat up to 80-90°C, and then add sodium carboxymethyl cellulose, nano zinc oxide, and phthalic acid in sequence Dibutyl ester, talcum powder and chitin, mix well;
  • Step (2) Add alicyclic amine and lauryl hydroglyceride, and continue to stir for 30-60 min;
  • Step (3) Add ethylene glycol dropwise to the mixture obtained in Step (2) and stir evenly to obtain the adhesive.
  • the sterilization catalyst 111 described in this embodiment can be irradiated by an ultraviolet lamp to produce active particles such as ⁇ OH, ⁇ ClO 2 , ⁇ HO 2 , ⁇ O, etc., induce a chain reaction, and quickly kill viruses and bacteria. , Mold, and degrading chemical pollutants, eventually becoming carbon dioxide, water and trace mineral salts.
  • active particles such as ⁇ OH, ⁇ ClO 2 , ⁇ HO 2 , ⁇ O, etc.
  • active particles such as ⁇ OH, ⁇ ClO 2 , ⁇ HO 2 , ⁇ O, etc.
  • the inorganic porous carrier is immersed in a stable chlorine dioxide solution or a stable chlorite solution, and dried below a preset temperature threshold to a moisture content less than a rated threshold.
  • the steps of the sterilization catalyst 111 can specifically include the following two solutions.
  • the first scheme prepare a stable chlorine dioxide solution, use a high-purity chlorine dioxide generator to obtain chlorine dioxide gas with a purity of ⁇ 98%, and use peroxyhydrate sodium carbonate (chemical formula is NaCO ⁇ mHO ⁇ nHO) as a stable And prepare a certain proportion of absorption liquid, and finally prepare a solution with a chlorine dioxide content of 2% to 5%.
  • the second scheme prepare a stable sodium chlorite solution, the content of each component in the solution is as follows: chlorite 0.1-10, stabilizer 0.1-5, buffer 0.05-15, absorbent 0.1-75.
  • the chlorite in this embodiment refers to a salt containing chlorite ion ClO, such as sodium chlorite, potassium chlorite, lithium chlorite, such as sodium chlorite, potassium chlorite, and chlorite lithium.
  • the stabilizer is also a strong oxidant, such as potassium permanganate, HO, perchlorate, nitrate and the like.
  • the buffering agent refers to a substance that can maintain the pH of the solution within a certain range, and is generally a salt.
  • salts with strong bases and weak acids such as sodium carbonate or borate, can be used. , Citrate, etc.
  • the absorbent refers to a chemical absorbent, which has a chemical reaction with the solute.
  • the solubility of the solute is not only related to the law of gas-liquid equilibrium, but also related to the law of chemical equilibrium.
  • Chemical absorbents are mostly solutions of certain active components, such as aqueous solutions of potassium carbonate, sodium carbonate, sodium hydroxide, and potassium hydroxide.
  • the step of preparing the sterilization and disinfection catalyst 111 in powder form may specifically include the following processes:
  • meltblown nonwoven fabric 110 and the spunbonded nonwoven fabric prepared in this embodiment have better viscosity strength and air permeability, and save and greatly reduce the production cost.
  • the protective equipment and sterilization and disinfection composite sheet of this embodiment can be applied to the above-mentioned purposes, and can also be specially provided for decoration workers to use to help the decoration workers remove formaldehyde, benzene and other toxic and harmful environments during decoration. Gas, to avoid health problems caused by decoration workers who are exposed to toxic and harmful gases for a long time.
  • the car owners and users suffer from leukemia due to the presence of formaldehyde, which will seriously endanger their health.
  • the user can wear the protective equipment of this application, sterilization and disinfection compound
  • the sheet, used as a mask can efficiently decompose and remove formaldehyde in the vehicle, ensuring the safety of users in the vehicle.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Textile Engineering (AREA)
  • Environmental & Geological Engineering (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Manufacturing & Machinery (AREA)
  • Plant Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Agronomy & Crop Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
  • Laminated Bodies (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)

Abstract

一种防护器具、杀菌消毒复合片材及其制备方法，杀菌消毒复合片材至少设置第一片材层（11），第一片材层（11）包括熔喷法非织造布（110）和以粉状形式复合到熔喷法非织造布（110）上的杀菌消毒催化剂（111），杀菌消毒催化剂（110）用于产生包括气相自由基·OH、·ClO 2、·HO 2、·O的多种活性粒子，用在伤口、口鼻或感染性皮肤时，通过多种活性粒子进行吸附、氧化、和/或净化。

Description

一种防护器具、杀菌消毒复合片材及其制造方法 技术领域
优先权声明：本申请要求在中国提交的发明专利申请CN201910212050.9、申请日期为2019年03月20日以及实用新型专利申请CN201920361187.6、申请日期为2019年03月20日的优先权。
本申请涉及杀菌消毒技术领域，具体涉及一种防护器具、杀菌消毒复合片材，还涉及所述杀菌消毒复合片材的制造方法。
背景技术
在空气过滤、净化、杀菌和消毒行业内，需要大量高透气效能又低阻力的涤纶材料，以用在过滤袋、过滤芯和净化器的复合材料中。目前市场上现在多出现的是涤纶长纤维工艺制造的基材。这种长纤维工艺的基材由于受到长纤维工艺影响的限制，布面不均匀、透气性低、成本高等因数的影响，从而造成做出空滤产品的性能效果不理想等系列问题的出现。
另一方面，一般的创可贴采用的杀菌消毒材料效果偏低，更加无法针对病毒性皮肤进行杀菌处理，所以应用范围窄，无法满足用户的需求。
有鉴于此，本申请的发明人经过深入研究，以寻求一种新的杀菌消毒产品，满足用户的日常生活需求。
发明内容
本申请的目的在于，提供一种防护器具、杀菌消毒复合片材及其制造方法，以进一步满足用户对日常的杀菌消毒需求，改善用户体验。
为解决上述技术问题，本申请提供一种杀菌消毒复合片材，作为其中一种实施方式，所述杀菌消毒复合片材至少设置有第一片材层，所述第一片材层包括熔喷法非织造布和以粉状形式复合到所述熔喷法非织造布上的杀菌消毒催化 剂，所述杀菌消毒催化剂用于产生包括气相自由基·OH、·ClO 2、·HO 2、·O的多种活性粒子，以在伤口、口鼻或感染性皮肤时，通过所述多种活性粒子进行吸附、氧化和/或净化。
作为其中一种实施方式，所述杀菌消毒复合片材至少还设置有第二片材层，所述第二片材层包括纺粘法非织造布，所述熔喷法非织造布与所述纺粘法非织造布进行复合并固结叠合，且所述杀菌消毒催化剂复合到所述熔喷法非织造布与所述纺粘法非织造布之间。
作为其中一种实施方式，所述熔喷法非织造布采用PP熔喷、PP熔喷结合PET、或静电棉结合PET的方式制得，且其平方米质量单重介于80-120g/m 2之间，厚度介于0.45-0.7mm之间，效率介于95％-99.99％之间。
作为其中一种实施方式，所述杀菌消毒催化剂包括无机多孔性载体，其中，所述杀菌消毒催化剂经由所述无机多孔性载体浸渍稳定性二氧化氯溶液或稳定性亚氯酸盐溶液后，经低于预设温度阈值干燥至含水率少于额定阈值制得，所述多种活性粒子可用于吸附并氧化杀灭微生物或甲醛。
作为其中一种实施方式，所述杀菌消毒催化剂为孔密度介于30目-60目的粉状颗粒物，且其平方米质量单重介于50-200g/m 2之间。
作为其中一种实施方式：
所述无机多孔性载体为堇青石蜂窝陶瓷或莫来石蜂窝陶瓷；
或，所述无机多孔性载体为三氧化二铝、二氧化硅、沸石、海泡石、蒙脱石和硅藻土中的至少其中一种或多种组合。
作为其中一种实施方式：
所述稳定性二氧化氯溶液采用二氧化氯气体和过氧水合碳酸钠制备得到，且二氧化氯含量为2％-5％；
所述稳定性亚氯酸盐溶液包括组分含量为0.1-10的亚氯酸盐、组分含量为0.1-5的稳定剂、组分含量为0.05-15的缓冲剂和组分含量为0.1-75的吸收剂，其中，所述亚氯酸盐为亚氯酸的碱金属盐或亚氯酸的碱土金属盐。
作为其中一种实施方式，所述杀菌消毒复合片材还包括用于粘贴的粘黏部，所述粘黏部自所述杀菌消毒复合片材延伸至突出于外周设置，以将杀菌消毒复合片材粘黏固定覆盖到伤口或感染性皮肤上，或粘黏到口罩上。
作为其中一种实施方式，所述粘黏部包括弹性基材以及形成于所述弹性基 材上的胶黏剂，所述胶粘剂包括质量份数为30份的环氧树脂、质量份数为21份的脂环胺、质量份数为7份的十二烷基水甘油醚、质量份数为3份的羧甲基纤维素钠、质量份数为0.6份的纳米氧化锌、质量份数为1.2份的硅胶、质量份数为2份的邻苯二甲酸二丁酯、质量份数为0.3份的滑石粉、质量份数为0.2份的甲壳素和质量份数为5份的乙二醇。
作为其中一种实施方式，所述第一片材层和/或所述第二片材层中用于实现粘结的增塑替代材料为：偏苯三酸三辛酯、环氧大豆油、DINCH、高分子增塑剂、乙烯-醋酸乙烯共聚物或聚氨酯，且不包括鄰苯二甲酸酐二丁脂。
为解决上述技术问题，本申请还提供一种防护器具，作为其中一种实施方式，所述防护器具采用如上所述的杀菌消毒复合片材，所述杀菌消毒复合片材包括一片第一片材层和两片第二片材层，所述第一片材层夹设于两片第二片材层之间，所述第一片材层包括熔喷法非织造布和以粉状形式复合到所述熔喷法非织造布上的杀菌消毒催化剂，所述杀菌消毒催化剂用于产生包括气相自由基·OH、·ClO 2、·HO 2、·O的多种活性粒子，所述第二片材层包括纺粘法非织造布，所述熔喷法非织造布与所述纺粘法非织造布进行复合并固结叠合，且所述杀菌消毒催化剂复合到所述熔喷法非织造布与所述纺粘法非织造布之间。
作为其中一种实施方式，所述防护器具为口罩、伤口护理贴或皮肤感染护理贴。
为解决上述技术问题，本申请还提供一种杀菌消毒复合片材的制造方法，作为其中一种实施方式，所述制造方法包括：
制得粉状形式的杀菌消毒催化剂，所述杀菌消毒催化剂用于产生包括气相自由基·OH、·ClO 2、·HO 2、·O的多种活性粒子；
制得熔喷法非织造布和纺粘法非织造布，并将所述熔喷法非织造布、所述纺粘法非织造布和所述杀菌消毒催化剂进行复合并固结叠合，其中，所述杀菌消毒催化剂复合到所述熔喷法非织造布上形成第一片材层，所述纺粘法非织造布形成第二片材层且所述杀菌消毒催化剂复合到所述熔喷法非织造布与所述纺粘法非织造布之间。
作为其中一种实施方式：
所述制得粉状形式的杀菌消毒催化剂的步骤，具体包括：
制备无机多孔性载体，将所述无机多孔性载体浸渍稳定性二氧化氯溶液或 稳定性亚氯酸盐溶液，经低于预设温度阈值干燥至含水率少于额定阈值制得所述杀菌消毒催化剂；
所述制得熔喷法非织造布和纺粘法非织造布，并将所述熔喷法非织造布、所述纺粘法非织造布和所述杀菌消毒催化剂进行复合并固结叠合的步骤之后，还包括：
在所述第一片材层和/或所述第二片材层上设置一弹性基材，并在所述弹性基材上形成胶粘剂，以形成用于粘贴的粘黏部，其中，所述胶粘剂包括质量份数为30份的环氧树脂、质量份数为21份的脂环胺、质量份数为7份的十二烷基水甘油醚、质量份数为3份的羧甲基纤维素钠、质量份数为0.6份的纳米氧化锌、质量份数为1.2份的硅胶、质量份数为0.3份的滑石粉、质量份数为0.2份的甲壳素和质量份数为5份的乙二醇。
有益效果：本申请提供一种防护器具、杀菌消毒复合片材及其制造方法，所述杀菌消毒复合片材至少设置有第一片材层，所述第一片材层包括熔喷法非织造布和以粉状形式复合到所述熔喷法非织造布上的杀菌消毒催化剂，用于产生包括气相自由基·OH、·ClO 2、·HO 2、·O的多种活性粒子，以在伤口、口鼻或感染性皮肤时，通过所述多种活性粒子进行吸附、氧化和/或净化。通过上述方式，本申请能够将杀菌消毒催化剂与创可贴或口罩的功能相结合，除了能够对空气进行净化，还能够对人体或者空气中的微生物进行杀菌消毒，给用户提供更加安全干净的体验，保障用户健康安全，改善用户体验，满足用户更多的日常需求。同时，本申请利用该气相自由基有效功效的空间距离极度有限的特性，且其以气相自由基存在的寿命时间仅约为10纳秒，因而不会进入到人体内，避免对人体带来伤害。
附图说明
为了更清楚地说明本申请实施例技术方案，下面将对实施例描述中所需要使用的附图作简单地介绍，显而易见地，下面描述中的附图是本申请的一些实施例，对于本领域普通技术人员来讲，在不付出创造性劳动的前提下，还可以根据这些附图获得其他的附图。
图1为本申请杀菌消毒复合片材一实施方式的结构示意图。
图2为图1杀菌消毒复合片材沿A-A’方向的剖面示意图。
图3为本申请杀菌消毒复合片材的制造方法一实施方式的流程示意图。
具体实施方式
为更进一步阐述本申请为达成预定申请目的所采取的技术手段及功效,以下结合附图及较佳实施例，对本申请详细说明如下。
通过具体实施方式的说明,当可对本申请为达成预定目的所采取的技术手段及效果得以更加深入且具体的了解，然而所附图式仅是提供参考与说明之用,并非用来对本申请加以限制。
请参阅图1和图2，在本实施方式中，本申请所述杀菌消毒复合片材至少设置有第一片材层11，所述第一片材层11包括熔喷法非织造布110和以粉状形式复合到所述熔喷法非织造布110上的杀菌消毒催化剂111，所述杀菌消毒催化剂111用于产生包括气相自由基·OH、·ClO 2、·HO 2、·O的多种活性粒子，以在伤口、口鼻或感染性皮肤时，通过所述多种活性粒子进行吸附、氧化和/或净化。通过这种方式，可以实现创可贴的高效杀菌消毒作用，还可以设置在口罩上进行杀菌消毒净化，或者对各种皮肤病进行杀菌消毒等，满足用户的不同使用需求。
首先需要强调的是，本实施方式所述气相自由基·OH、·ClO 2、·HO 2、·O的多种活性粒子，其作为气相时的有效活动距离以微米为度量单位，且其以气相自由基存在的寿命时间仅约为10纳秒，即其基本上不能脱离杀菌消毒催化剂111的载体而存在，因此，本实施方式的气相自由基·OH、·ClO 2、·HO 2、·O的多种活性粒子不会作为强氧化剂而进入人体内，避免给人体带来不必要的伤害，而仅仅是在杀菌消毒催化剂111的载体所在的极小距离范围内有效、并对企图穿越杀菌消毒催化剂111的细菌、病毒等进行有效的消杀，确保用户的使用安全。
值得一提的是，本实施方式在图1及图2中，可以不设置标号为13的部件，其只在某些特殊用途时才需要设置该部件，在本实施方式中不作细述。
需要说明的是，本实施方式所述杀菌消毒复合片材至少还设置有第二片材层12，所述第二片材层12包括纺粘法非织造布，所述熔喷法非织造布110与 所述纺粘法非织造布进行复合并固结叠合，且所述杀菌消毒催化剂111复合到所述熔喷法非织造布110与所述纺粘法非织造布之间。
不难理解的是，本实施方式的杀菌消毒复合片材设置成SM的复合方式，即一熔喷法非织造布110(M)复合一纺粘法非织造布(S)，而在其他实施方式中，也可以复合成SMS，SMMMS等方式，且可以在不同的M层上，根据需要而复合不同的材料，并实现不同的功能，在此不作限定。此外，其可以采用一步法进行复合，也可以采用两步法进行复合，在本技术领域人员理解的范围内，不作细述。
本申请采用熔喷法非织造布110(M)复合一纺粘法非织造布(S)的方式，充分利用两种非织造布的特性，即保证了整体的柔韧度、结构强度，也保证了透气性和过滤率的弹性需求。
值得一提的是，本实施方式采用的复合固结叠合方式可以为热轧、针刺、水刺和超声波。
在本实施方式中，所述熔喷法非织造布110采用PP(聚丙烯)熔喷、PP熔喷结合PET(聚酯)、或静电棉结合PET的方式制得，且其平方米质量单重介于80-120g/m 2(克每平方米)之间，厚度介于0.45-0.7mm(毫米)之间，效率介于95％-99.99％之间。
举例而言，平方米质量单重可以为90g/m 2、95g/m 2、100g/m 2、105g/m 2或者110g/m 2，而厚度可以为0.5mm、0.55mm、0.6mm和0.7mm，效率为95％、96％、99％和99.99％，其具体可以视应用途径而设定。
需要详细说明的是，本实施方式所述杀菌消毒催化剂111包括无机多孔性载体，其中，所述杀菌消毒催化剂111经由所述无机多孔性载体浸渍稳定性二氧化氯溶液或稳定性亚氯酸盐溶液后，经低于预设温度阈值干燥至含水率少于额定阈值制得，所述多种活性粒子可用于吸附并氧化杀灭微生物或甲醛。
其中，所述预设温度阈值可以为85℃或者90℃等，所述额定阈值可以为10％、9％、8％或者7％等。
值得一提的是，本实施方式所述杀菌消毒催化剂111为孔密度介于30目-60目的粉状颗粒物，且其平方米质量单重介于50-200g/m 2之间。优选地，可以采用40目、45目或者50目，平方米质量单重则可以为60g/m 2、70g/m 2、80g/m 2、90g/m 2、100g/m 2、160g/m 2、140g/m 2等等，其可以根据应用途径而具体设 定。
在本实施方式中，所述无机多孔性载体为堇青石蜂窝陶瓷或莫来石蜂窝陶瓷；或，所述无机多孔性载体为三氧化二铝、二氧化硅、沸石、海泡石、蒙脱石和硅藻土中的至少其中一种或多种组合。其具体可以采用混合等方式，在此不作限定。
值得一提的是，本实施方式所述稳定性二氧化氯溶液采用二氧化氯气体和过氧水合碳酸钠制备得到，且二氧化氯含量为2％-5％。优选地，二氧化氯含量可以为3％，4％。
此外，本实施方式所述稳定性亚氯酸盐溶液包括组分含量为0.1-10的亚氯酸盐、组分含量为0.1-5的稳定剂、组分含量为0.05-15的缓冲剂和组分含量为0.1-75的吸收剂，其中，所述亚氯酸盐为亚氯酸的碱金属盐或亚氯酸的碱土金属盐。
需要说明的是，在实现创可贴式的粘贴功能时，比如贴到手臂、肚子、背部或者头部等时，需要采用胶布或者胶带捆绑等方式，而为了方便用户，本实施方式所述杀菌消毒复合片材还包括用于粘贴的粘黏部13，所述粘黏部13自所述杀菌消毒复合片材延伸至突出于外周设置，以将杀菌消毒复合片材粘黏固定覆盖到伤口或感染性皮肤上，或粘黏到口罩上。
其中，所述粘黏部13的形状可以针对关节、手指、头部等不同部位的形状，而对应设置成不同的方式，比如环状、多个粘黏部13间隔设置状等。
具体而言，本实施方式所述粘黏部13包括弹性基材以及形成于所述弹性基材上的胶黏剂，所述胶粘剂包括质量份数为30份的环氧树脂、质量份数为21份的脂环胺、质量份数为7份的十二烷基水甘油醚、质量份数为3份的羧甲基纤维素钠、质量份数为0.6份的纳米氧化锌、质量份数为1.2份的硅胶、质量份数为0.3份的滑石粉、质量份数为0.2份的甲壳素和质量份数为5份的乙二醇。
采用本实施方式胶黏剂，可以极大地改善皮肤时的使用体验，能够提供较好的透气性，还能保证粘黏强度，以及起到很好的防水效果。
值得一提的是，本实施方式所述第一片材层11和/或第二片材层12中用于实现粘结的增塑替代材料为：偏苯三酸三辛酯、环氧大豆油、DINCH(非邻苯二甲酸酯)、高分子增塑剂、乙烯-醋酸乙烯共聚物或聚氨酯，且不包括鄰苯二甲 酸酐二丁脂。不难理解的是，本实施方式不再采用鄰苯二甲酸酐二丁脂作为增塑剂，避免在作为防护器具时给人体带来的危害，进而可以保障人体健康，提高产品的安全性能。
请继续参阅图1、图2及其实施方式所述，本申请还提供一种防护器具，作为其中一种实施方式，所述防护器具采用如上所述的杀菌消毒复合片材，所述杀菌消毒复合片材包括一片第一片材层(M)和两片第二片材层(S)，所述第一片材层(M)夹设于两片第二片材层(S)之间，所述第一片材层(M)包括熔喷法非织造布和以粉状形式复合到所述熔喷法非织造布上的杀菌消毒催化剂，所述杀菌消毒催化剂用于产生包括气相自由基·OH、·ClO 2、·HO 2、·O的多种活性粒子，所述第二片材层(S)包括纺粘法非织造布，所述熔喷法非织造布与所述纺粘法非织造布进行复合并固结叠合，且所述杀菌消毒催化剂复合到所述熔喷法非织造布与所述纺粘法非织造布之间。
容易理解的是，本实施方式的防护器具采用的杀菌消毒复合片材设置的方式为SMS无纺布(Spun bond，Melt blown，Spun bond Nonwovens)的方式，即复合无纺布，其可以具有强力高、过滤性能好、不含粘合剂、无毒等优点，而且复合了杀菌消毒复合片材的性能，可以很好地用于生活中进行防护护理。
需要说明的是，本实施方式所述防护器具可以为口罩、伤口护理贴或皮肤感染护理贴等。
本实施方式防护器具作为口罩使用时，通过气相自由基·OH、·ClO 2、·HO 2、·O的多种活性粒子，首先，能够将自外部吸入口罩内的细菌病毒进行消杀，以避免被外部感染，其次，能够将来自作为感染用户的口罩佩戴者的呼出细菌病毒进行消杀，避免其扩散至外部环境而致使他人感染，最后，本申请的口罩，还可以释放痕量的·ClO 2至口罩佩戴者的口腔、呼吸道内，既可以实现杀菌消毒，还通过其抗氧化作用，促进人体的新陈代谢。
需要特别指出的是，本申请能够通过气相自由基·OH、·ClO 2、·HO 2、·O的多种活性粒子实现对冠状病毒进行有效的防治和消杀，比如SARS、COVID-19新型冠状病毒等，能够协助感染者进行快速康复。
请结合图1和图2参阅图3，本申请还提供一种用于制造如上实施方式所述杀菌消毒复合片材的制造方法，具体而言，本实施方式所述制造方法包括但不限于如下步骤。
步骤S301，制得粉状形式的杀菌消毒催化剂111，所述杀菌消毒催化剂111用于产生包括气相自由基·OH、·ClO 2、·HO 2、·O的多种活性粒子；
步骤S302，制得熔喷法非织造布110和纺粘法非织造布，并将所述熔喷法非织造布110、所述纺粘法非织造布和所述杀菌消毒催化剂111进行复合并固结叠合，其中，所述杀菌消毒催化剂111复合到所述熔喷法非织造布110上形成第一片材层11，所述纺粘法非织造布形成第二片材层12且所述杀菌消毒催化剂111复合到所述熔喷法非织造布110与所述纺粘法非织造布之间。
具体而言，本实施方式所述制得粉状形式的杀菌消毒催化剂111的步骤，具体包括：制备无机多孔性载体，将所述无机多孔性载体浸渍稳定性二氧化氯溶液或稳定性亚氯酸盐溶液，经低于预设温度阈值干燥至含水率少于额定阈值制得所述杀菌消毒催化剂111。
值得一提的是，本实施方式所述制得熔喷法非织造布110和纺粘法非织造布，并将所述熔喷法非织造布110、所述纺粘法非织造布和所述杀菌消毒催化剂111进行复合并固结叠合的步骤之后，还包括：在所述第一片材层11和/或所述第二片材层12上设置一弹性基材，并在所述弹性基材上形成胶粘剂，以形成用于粘贴的粘黏部13，其中，所述胶粘剂包括质量份数为30份的环氧树脂、质量份数为21份的脂环胺、质量份数为7份的十二烷基水甘油醚、质量份数为3份的羧甲基纤维素钠、质量份数为0.6份的纳米氧化锌、质量份数为1.2份的硅胶、质量份数为0.3份的滑石粉、质量份数为0.2份的甲壳素和质量份数为5份的乙二醇。
其中，本实施方式所述硅胶可以为细孔硅胶，平均孔距2.0-3.0nm(纳米)。
具体而言，本实施方式在所述第一片材层11和/或所述第二片材层12上设置一弹性基材，并在所述弹性基材上形成胶粘剂，以形成用于粘贴的粘黏部13的步骤，可以包括如下具体步骤制得胶粘剂：
步骤(1)按照质量配比，将环氧树脂和硅胶混合，搅拌30-60min(分钟)，升温至80-90℃，再依次加入羧甲基纤维素钠、纳米氧化锌、邻苯二甲酸二丁酯、滑石粉和甲壳素，搅拌均匀；
步骤(2)再加入脂环胺和十二烷基水甘油醚，继续搅拌30-60min；
步骤(3)向步骤(2)所得混合物中滴加乙二醇，搅拌均匀，即得所述胶黏剂。
需要指出的是，本实施方式所述杀菌消毒催化剂111，可以经紫外线灯照 射,产生·OH、·ClO 2、·HO 2、·O等活性粒子,诱发链式反应,迅速杀灭病毒、细菌、霉菌和降解化学污染物,最终成为二氧化碳、水和微量矿盐。当然，在其他实施方式中，也可以根据治理环境和治理对象的不同,可不经紫外线灯照射,直接作为催化氧化材料,同样可以降解化学污染物和杀灭病毒、细菌、霉菌等微生物,达到同样净化效果。
需要详细说明的是，本实施方式将所述无机多孔性载体浸渍稳定性二氧化氯溶液或稳定性亚氯酸盐溶液，经低于预设温度阈值干燥至含水率少于额定阈值制得所述杀菌消毒催化剂111的步骤，具体可以包括如下两种方案。
第一方案:配制稳定性二氧化氯溶液,用高纯度二氧化氯发生器得到纯度≥98％的二氧化氯气体,以过氧水合碳酸钠(化学通式为NaCO·mHO·nHO)作为稳定剂,配成一定比例的吸收液,最后制备成二氧化氯含量为2％-5％的溶液。
第二方案:配制稳定性亚氯酸钠溶液,该溶液中各组分含量如下:亚氯酸盐0.1-10,稳定剂0.1-5,缓冲剂0.05-15,吸收剂0.1-75。
具体而言，本实施方式所述亚氯酸盐指含亚氯酸根离子ClO的盐,例如:亚氯酸钠、亚氯酸钾、亚氯酸锂，如亚氯酸钠、亚氯酸钾、亚氯酸锂。
其中，所述稳定剂也是强氧化剂,例如:高锰酸钾、HO、高氯酸盐、硝酸盐等。
在本实施方式中，所述缓冲剂是指能使溶液pH值在一定范围内维持基本恒定的物质,一般是盐类,在这里只能用强碱弱酸的盐,如碳酸钠或硼酸盐、柠檬酸盐等。
相应地，所述吸收剂是指化学吸收剂,与溶质之间有化学反应,溶质的溶解度不仅与气液平衡规律有关,而且与化学平衡规律有关。化学吸收剂大多是某种活性组分的溶液,例如碳酸钾、碳酸钠、氢氧化钠、氢氧化钾的水溶液等。
上述两种方案中一种作为浸渍液,浸渍上述任何一种无机多孔载体,经85℃以下温度干燥直至含水率≤8％,得到我们所需要的催化材料。
在本申请的一具体实施例中，制得粉状形式的杀菌消毒催化剂111的步骤，具体可以包括如下流程：
首先制取稳定性亚氯酸钠稳定溶液,量取5000ml(毫升)纯净水,称取400g(克)含量80％的亚氯酸钠,在水中溶解后,称取氯化钠100g继续在水中搅拌溶化,然后加入20g四合水硼酸钠,最后加20ml含量30％过氧化氢,搅拌后过滤, 最后用碳酸钠调整pH值8.0-9.5之间。然后加入3000g二氧化硅全部浸渍在液体中,不停搅拌,1～2小时后,沥尽余液,风扇吹干并放在65℃真空加热炉干燥,至含水率≤8％即可出炉冷却备用。
本实施方式制得熔喷法非织造布110和纺粘法非织造布，具有更好的粘度强度和透气性，并且节约大大的降低了生产制造成本。
值得说明的是，本实施方式的防护器具和杀菌消毒复合片材，除了可以应用到上述用途外，还可以专门提供给装修工人使用，帮助装修工人去除装修时环境中包括甲醛、苯等有毒有害气体，避免装修工人长期处于有毒有害气体环境下所带来的健康问题。
在具体的应用场景中，针对一些用材质量不好的车辆，由于甲醛的存在而导致车主用户患上白血病等而严重危害身体健康，此时，用户可以佩戴上本申请的防护器具、杀菌消毒复合片材，作为口罩使用，能够对车辆内存在的甲醛等进行高效的分解和清除，确保用户用车安全。
以上所述，仅是本申请的较佳实施例而已，并非对本申请作任何形式上的限制，虽然本申请已以较佳实施例揭露如上，然而并非用以限定本申请,任何熟悉本专业的技术人员，在不脱离本申请技术方案范围内,当可利用上述揭示的技术内容作出些许更动或修饰为等同变化的等效实施例,但凡是未脱离本申请技术方案内容，依据本申请的技术实质对以上实施例所作的任何简单修改、等同变化与修饰,均仍属于本申请技术方案的范围内。

Claims (20)

  1. 一种杀菌消毒复合片材，其中，所述杀菌消毒复合片材至少设置有第一片材层，所述第一片材层包括熔喷法非织造布和以粉状形式复合到所述熔喷法非织造布上的杀菌消毒催化剂，所述杀菌消毒催化剂用于产生包括气相自由基·OH、·ClO2、·HO2、·O的多种活性粒子，以在伤口、口鼻或感染性皮肤时，通过所述多种活性粒子进行吸附、氧化和/或净化。
  2. 根据权利要求1所述的杀菌消毒复合片材，其中，所述杀菌消毒复合片材至少还设置有第二片材层，所述第二片材层包括纺粘法非织造布，所述熔喷法非织造布与所述纺粘法非织造布进行复合并固结叠合，且所述杀菌消毒催化剂复合到所述熔喷法非织造布与所述纺粘法非织造布之间。
  3. 根据权利要求2所述的杀菌消毒复合片材，其中，所述熔喷法非织造布采用PP熔喷、PP熔喷结合PET、或静电棉结合PET的方式制得，且其平方米质量单重介于80-120g/m 2之间，厚度介于0.45-0.7mm之间，效率介于95％-99.99％之间。
  4. 根据权利要求2所述的杀菌消毒复合片材，其中，所述杀菌消毒催化剂包括无机多孔性载体，其中，所述杀菌消毒催化剂经由所述无机多孔性载体浸渍稳定性二氧化氯溶液或稳定性亚氯酸盐溶液后，经低于预设温度阈值干燥至含水率少于额定阈值制得，所述多种活性粒子可用于吸附并氧化杀灭微生物或甲醛。
  5. 根据权利要求4所述的杀菌消毒复合片材，其中，所述杀菌消毒催化剂为孔密度介于30目-60目的粉状颗粒物，且其平方米质量单重介于50-200g/m 2之间。
  6. 根据权利要求5所述的杀菌消毒复合片材，其中：
    所述无机多孔性载体为堇青石蜂窝陶瓷或莫来石蜂窝陶瓷；
    或，所述无机多孔性载体为三氧化二铝、二氧化硅、沸石、海泡石、蒙脱石和硅藻土中的至少其中一种或多种组合。
  7. 根据权利要求4所述的杀菌消毒复合片材，其中：
    所述稳定性二氧化氯溶液采用二氧化氯气体和过氧水合碳酸钠制备得到， 且二氧化氯含量为2％-5％；
    所述稳定性亚氯酸盐溶液包括组分含量为0.1-10的亚氯酸盐、组分含量为0.1-5的稳定剂、组分含量为0.05-15的缓冲剂和组分含量为0.1-75的吸收剂，其中，所述亚氯酸盐为亚氯酸的碱金属盐或亚氯酸的碱土金属盐。
  8. 根据权利要求1所述的杀菌消毒复合片材，其中，所述杀菌消毒复合片材还包括用于粘贴的粘黏部，所述粘黏部自所述杀菌消毒复合片材延伸至突出于外周设置，以将杀菌消毒复合片材粘黏固定覆盖到伤口或感染性皮肤上，或粘黏到口罩上。
  9. 根据权利要求8所述的杀菌消毒复合片材，其中，所述粘黏部包括弹性基材以及形成于所述弹性基材上的胶黏剂，所述胶粘剂包括质量份数为30份的环氧树脂、质量份数为21份的脂环胺、质量份数为7份的十二烷基水甘油醚、质量份数为3份的羧甲基纤维素钠、质量份数为0.6份的纳米氧化锌、质量份数为1.2份的硅胶、质量份数为2份的邻苯二甲酸二丁酯、质量份数为0.3份的滑石粉、质量份数为0.2份的甲壳素和质量份数为5份的乙二醇。
  10. 根据权利要求2所述的杀菌消毒复合片材，其中，所述第一片材层和/或所述第二片材层中用于实现粘结的增塑替代材料为：偏苯三酸三辛酯、环氧大豆油、DINCH、高分子增塑剂、乙烯-醋酸乙烯共聚物或聚氨酯，且不包括鄰苯二甲酸酐二丁脂。
  11. 一种防护器具，其中，所述防护器具采用如权利要求1所述的杀菌消毒复合片材，所述杀菌消毒复合片材包括一片第一片材层和两片第二片材层，所述第一片材层夹设于两片第二片材层之间，所述第一片材层包括熔喷法非织造布和以粉状形式复合到所述熔喷法非织造布上的杀菌消毒催化剂，所述杀菌消毒催化剂用于产生包括气相自由基·OH、·ClO 2、·HO 2、·O的多种活性粒子，所述第二片材层包括纺粘法非织造布，所述熔喷法非织造布与所述纺粘法非织造布进行复合并固结叠合，且所述杀菌消毒催化剂复合到所述熔喷法非织造布与所述纺粘法非织造布之间。
  12. 根据权利要求11所述的防护器具，其中，所述防护器具为口罩、伤口护理贴或皮肤感染护理贴。
  13. 根据权利要求12所述的防护器具，其中，所述杀菌消毒复合片材至少还设置有第二片材层，所述第二片材层包括纺粘法非织造布，所述熔喷法非织 造布与所述纺粘法非织造布进行复合并固结叠合，且所述杀菌消毒催化剂复合到所述熔喷法非织造布与所述纺粘法非织造布之间。
  14. 根据权利要求13所述的防护器具，其中，所述熔喷法非织造布采用PP熔喷、PP熔喷结合PET、或静电棉结合PET的方式制得，且其平方米质量单重介于80-120g/m 2之间，厚度介于0.45-0.7mm之间，效率介于95％-99.99％之间。
  15. 根据权利要求13所述的防护器具，其中，所述杀菌消毒催化剂包括无机多孔性载体，其中，所述杀菌消毒催化剂经由所述无机多孔性载体浸渍稳定性二氧化氯溶液或稳定性亚氯酸盐溶液后，经低于预设温度阈值干燥至含水率少于额定阈值制得，所述多种活性粒子可用于吸附并氧化杀灭微生物或甲醛。
  16. 根据权利要求15所述的防护器具，其中，所述杀菌消毒催化剂为孔密度介于30目-60目的粉状颗粒物，且其平方米质量单重介于50-200g/m 2之间。
  17. 根据权利要求16所述的防护器具，其中：
    所述无机多孔性载体为堇青石蜂窝陶瓷或莫来石蜂窝陶瓷；
    或，所述无机多孔性载体为三氧化二铝、二氧化硅、沸石、海泡石、蒙脱石和硅藻土中的至少其中一种或多种组合。
  18. 根据权利要求15所述的防护器具，其中：
    所述稳定性二氧化氯溶液采用二氧化氯气体和过氧水合碳酸钠制备得到，且二氧化氯含量为2％-5％；
    所述稳定性亚氯酸盐溶液包括组分含量为0.1-10的亚氯酸盐、组分含量为0.1-5的稳定剂、组分含量为0.05-15的缓冲剂和组分含量为0.1-75的吸收剂，其中，所述亚氯酸盐为亚氯酸的碱金属盐或亚氯酸的碱土金属盐。
  19. 一种杀菌消毒复合片材的制造方法，其中，用于制造如权利要求1所述的杀菌消毒复合片材，所述制造方法包括：
    制得粉状形式的杀菌消毒催化剂，所述杀菌消毒催化剂用于产生包括气相自由基·OH、·ClO 2、·HO 2、·O的多种活性粒子；
    制得熔喷法非织造布和纺粘法非织造布，并将所述熔喷法非织造布、所述纺粘法非织造布和所述杀菌消毒催化剂进行复合并固结叠合，其中，所述杀菌消毒催化剂复合到所述熔喷法非织造布上形成第一片材层，所述纺粘法非织造布形成第二片材层且所述杀菌消毒催化剂复合到所述熔喷法非织造布与所述纺粘法非织造布之间。
  20. 根据权利要求19所述的制造方法，其中：
    所述制得粉状形式的杀菌消毒催化剂的步骤，具体包括：
    制备无机多孔性载体，将所述无机多孔性载体浸渍稳定性二氧化氯溶液或稳定性亚氯酸盐溶液，经低于预设温度阈值干燥至含水率少于额定阈值制得所述杀菌消毒催化剂；
    所述制得熔喷法非织造布和纺粘法非织造布，并将所述熔喷法非织造布、所述纺粘法非织造布和所述杀菌消毒催化剂进行复合并固结叠合的步骤之后，还包括：
    在所述第一片材层和/或所述第二片材层上设置一弹性基材，并在所述弹性基材上形成胶粘剂，以形成用于粘贴的粘黏部，其中，所述胶粘剂包括质量份数为30份的环氧树脂、质量份数为21份的脂环胺、质量份数为7份的十二烷基水甘油醚、质量份数为3份的羧甲基纤维素钠、质量份数为0.6份的纳米氧化锌、质量份数为1.2份的硅胶、质量份数为0.3份的滑石粉、质量份数为0.2份的甲壳素和质量份数为5份的乙二醇。
PCT/CN2020/076616 2019-03-20 2020-02-25 一种防护器具、杀菌消毒复合片材及其制造方法 WO2020186979A1 (zh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020207012626A KR20200113184A (ko) 2019-03-20 2020-02-25 보호 기구, 살균소독 복합 시트재 및 그의 제조방법
JP2020526223A JP2021518769A (ja) 2019-03-20 2020-02-25 保護具、殺菌消毒複合シートおよびその製造方法

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN201920361187.6U CN210125297U (zh) 2019-03-20 2019-03-20 一种防护器具及其杀菌消毒复合片材
CN201910212050.9 2019-03-20
CN201910212050.9A CN109794164A (zh) 2019-03-20 2019-03-20 一种防护器具、杀菌消毒复合片材及其制造方法
CN201920361187.6 2019-03-20

Publications (1)

Publication Number Publication Date
WO2020186979A1 true WO2020186979A1 (zh) 2020-09-24

Family

ID=72519606

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2020/076616 WO2020186979A1 (zh) 2019-03-20 2020-02-25 一种防护器具、杀菌消毒复合片材及其制造方法

Country Status (3)

Country Link
JP (1) JP2021518769A (zh)
KR (1) KR20200113184A (zh)
WO (1) WO2020186979A1 (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114505031A (zh) * 2021-12-29 2022-05-17 成都市图腾环保科技有限公司 一种汽车污染净化喷雾剂的制备方法
SE2251142A1 (en) * 2022-10-03 2024-04-04 Adsorbi Ab Adsorbent material

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220114293A (ko) 2021-02-08 2022-08-17 권강식 스핀트로닉스 기반 항균 조성물 제공 시스템 및 항균 조성물

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5227168A (en) * 1989-11-21 1993-07-13 Bruce Barber Method of treating a wound
CN101716362A (zh) * 2009-12-08 2010-06-02 北京欧凯纳斯科技有限公司 一种含二氧化氯的杀菌消毒材料及其应用
CN101812803A (zh) * 2009-12-21 2010-08-25 北京欧凯纳斯科技有限公司 一种可降解的消毒用非织造布及其制备方法
CN106072911A (zh) * 2016-06-29 2016-11-09 武汉纺织大学 一种可吸附有害气体的环保口罩及其制备方法
CN109794164A (zh) * 2019-03-20 2019-05-24 深圳市康风环境科技发展有限公司 一种防护器具、杀菌消毒复合片材及其制造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0199559A (ja) * 1987-10-12 1989-04-18 Daiso Co Ltd 安定化二酸化塩素剤
US6967261B1 (en) * 2001-12-28 2005-11-22 Kimberly-Clark Worldwide Bandage, methods of producing and using same
WO2009051018A1 (ja) * 2007-10-15 2009-04-23 Taiko Pharmaceutical Co., Ltd. 携帯式吸気殺菌装置
JP3150869U (ja) * 2009-03-17 2009-06-04 和夫 夏目 マスク用衛生フィルタ
JP5605744B2 (ja) * 2010-02-25 2014-10-15 ダイソー株式会社 安定化二酸化塩素剤および二酸化塩素の安定した発生方法
JP2012152327A (ja) * 2011-01-25 2012-08-16 Unitika Ltd 衛生マスク
JP6342778B2 (ja) * 2014-09-24 2018-06-13 入江　敏夫 正孔を保有する基材−シリカゾル乾燥物複合体及びその製造方法
JP2016124765A (ja) * 2015-01-06 2016-07-11 サンマテリアル株式会社 二酸化塩素剤、二酸化塩素剤封入製品および二酸化塩素剤キット
JP6680836B2 (ja) * 2017-08-03 2020-04-15 プロテックアート株式会社 マスク

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5227168A (en) * 1989-11-21 1993-07-13 Bruce Barber Method of treating a wound
CN101716362A (zh) * 2009-12-08 2010-06-02 北京欧凯纳斯科技有限公司 一种含二氧化氯的杀菌消毒材料及其应用
CN101812803A (zh) * 2009-12-21 2010-08-25 北京欧凯纳斯科技有限公司 一种可降解的消毒用非织造布及其制备方法
CN106072911A (zh) * 2016-06-29 2016-11-09 武汉纺织大学 一种可吸附有害气体的环保口罩及其制备方法
CN109794164A (zh) * 2019-03-20 2019-05-24 深圳市康风环境科技发展有限公司 一种防护器具、杀菌消毒复合片材及其制造方法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114505031A (zh) * 2021-12-29 2022-05-17 成都市图腾环保科技有限公司 一种汽车污染净化喷雾剂的制备方法
SE2251142A1 (en) * 2022-10-03 2024-04-04 Adsorbi Ab Adsorbent material

Also Published As

Publication number Publication date
KR20200113184A (ko) 2020-10-06
JP2021518769A (ja) 2021-08-05

Similar Documents

Publication Publication Date Title
WO2020186979A1 (zh) 一种防护器具、杀菌消毒复合片材及其制造方法
CN210125297U (zh) 一种防护器具及其杀菌消毒复合片材
CN109794164A (zh) 一种防护器具、杀菌消毒复合片材及其制造方法
CN107019270B (zh) 一种主动抗菌型生物防护口罩及其抗菌剂材料的合成工艺
JP7328288B2 (ja) 繰り返し水洗い可能な防護マスク及びその製造プロセス
CN205567899U (zh) 一种具有防雾霾功能的口罩
CN111938240A (zh) 一种高效抗菌杀毒的活性炭防护口罩
CN112370867A (zh) 一种高效抗菌防护口罩过滤层的制备方法
US20190201823A1 (en) Composite Material for Air Purification, Preparation Method therefor and Application thereof
CN110754720B (zh) 一种除湿自加热活性氧化铝立体式口罩
CN205757364U (zh) 一种新型口罩
CN107569915A (zh) 一种用于拦截pm1.0的空气净化材料及其制备方法
CN208658038U (zh) 一种抗菌透气面料
CN215270762U (zh) 一种采用分体盐疗包的盐疗口罩
CN112914173B (zh) 一种光催化磷灰石包裹技术杀菌消毒口罩
CN211185967U (zh) 口罩
CN211185966U (zh) 口罩
CN109011920B (zh) 一种抗菌空气过滤膜
TWM556614U (zh) 具抗菌除臭之口罩結構
CN112914178A (zh) 一种抗击新冠状病毒携袋式灭菌防护口罩
CN2609582Y (zh) 一种阻尘滤菌口罩
CN202112349U (zh) 一次性使用口罩
CN106014093A (zh) 一种基于物联网的智能呼吸窗
CN202504232U (zh) 含银锌复合物的抗菌医用口罩
CN211323155U (zh) 一种光触媒除菌口罩

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref document number: 2020526223

Country of ref document: JP

Kind code of ref document: A

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20774611

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20774611

Country of ref document: EP

Kind code of ref document: A1